Pakistan’s pharmaceutical industry is growing, but growth alone will not guarantee global competitiveness.

Pharmaceutical exports reached a record $457 million in FY2024–25, reflecting 34% year-on-year growth. The $30B goal within five years, set by the officials raise some urgent questions:

Can Pakistan achieve global-scale export growth while many pharmaceutical operations remain fragmented and disconnected?

This is what shaped Spectrum for Life, a landmark gathering powered by Spectrum – The Quality Management Platform and the discussion on Pharma 4.0: The Digital Shift for Better Lives, where pharmaceutical leaders, quality professionals, regulators, plant heads, and technology experts came together under one platform to discuss digital maturity, operational excellence, and the future of Pakistan’s pharmaceutical industry.

Technology Must Deliver Business Impact

Upon opening the event, Ayal Abbas, CEO of Sofcom, reflected on the company’s journey from the early days of mainframes and restricted computer access to today’s connected digital environment.

He recalled how Pakistani pharmaceutical companies once struggled to access enterprise technologies that were affordable, locally relevant, and capable of supporting complex industry requirements.

“The belief is that technology must deliver real business impact.” — Ayal Abbas, CEO, Sofcom.

His message established an important foundation for the event: technology should not be adopted simply because it is new. It should improve decision-making, strengthen operations, and produce measurable business outcomes.

Ayal Abbas also highlighted a long-standing vision of making intelligence accessible across the organization—not only to senior management, but to the employees capturing and using operational information every day.

The Real Problem: Disconnected Operations

The whole conversation was positioned as more than software, automation, or documentation.

It was the integration of people, plants, processes, labs, and data into a unified operating environment.

Disconnected operations affect more than internal efficiency. They can delay investigations, weaken traceability, slow product release, increase compliance risk, and ultimately affect time-to-market and export readiness.

Collaboration as the Starting Point

The event also demonstrated that Pakistan’s digital pharmaceutical transformation cannot be led by one organization alone.

The presence of senior professionals, quality leaders, plant heads, technology experts from leading pharmaceutical companies of Pakistan and regulators created a platform for shared learning and collective direction.

Ayal Abbas specifically acknowledged Dr. Saif Ur Rehman Khattak’s contribution to

Pakistan’s pharmaceutical sector and WHO prequalification efforts, while also recognizing the experience of guest speaker Nadeem Rehmat and other senior participants.

The discussion also called for stronger collaboration among manufacturers, regulators, technology providers, and industry professionals. Tahir Waqas supported more open engagement between industry and regulators:

“When the expertise of regulators and the experience of industry come together, problems can be identified earlier, corrective action becomes faster, and the industry can progress with greater confidence.”

Closing the event, the Director at Sofcom, Mehdi Raza described Spectrum for Life as a continuing platform:

“We want industry leaders to join hands, discuss real challenges, and share real transformation stories that can move the industry forward.”

Key Takeaways

• Begin with a clearly defined quality or operational problem—not with a technology purchase.
• Digitize high-impact workflows first, particularly smart manufacturing and batch records.
• Convert operational data into actionable dashboards for relevant decision-makers.
• Measure the cost of downtime, deviations, manual work, and delayed batch release.
• Engage employees early and build their confidence through training and participation.
• Introduce digitalization in manageable phases and scale after demonstrating value.
• Integrate quality, laboratory, production, and enterprise systems to eliminate data silos.

• Work proactively with regulators and technology partners to improve compliance and export readiness.